Skip to main content
Top
Published in: Virchows Archiv 1/2006

01-01-2006 | Original Article

Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?

Authors: Klaus Dirschmid, Claudia Platz-Baudin, Manfred Stolte

Published in: Virchows Archiv | Issue 1/2006

Login to get access

Abstract

It is well known from the older literature that gastric carcinomas are more likely to develop in a stomach containing hyperplastic polyps. The reason why such a stomach should represent a precancerous condition is, however, largely unexplained. The aim of this study was to determine the disorders of the gastric mucosa in which hyperplastic polyps occur. In 244 patients with hyperplastic polyp, in whom at least two additional biopsies each from the antrum and corpus were available, gastritis was classified on the basis of the updated Sydney System. In none of the 244 patients was the gastric mucosa found to be normal. The most common disorder, at 51.3%, was autoimmune gastritis of the corpus mucosa, while chronic active Helicobacter pylori (Hp) gastritis was seen in 37.3% of the patients. Of the patients with Hp gastritis, 56.1% had corpus-dominant Hp gastritis. Other forms were relatively rare: when A-gastritis, corpus-dominant Hp gastritis and any other form of Hp gastritis were lumped together as a precancerous condition, these changes were found in 88.6% of the patients with hyperplastic polyps of the stomach. In the presence of hyperplastic polyps of the gastric mucosa, additional biopsies obtained from the antrum and corpus should always be performed to obtain a basis for deciding whether to apply Hp eradication treatment as potential carcinoma prophylaxis.
Literature
1.
go back to reference Abraham SC, Singh VK, Yardley JH, Wu TT (2001) Hyperplastic polyps of the stomach. Associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol 25:500–507PubMedCrossRef Abraham SC, Singh VK, Yardley JH, Wu TT (2001) Hyperplastic polyps of the stomach. Associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol 25:500–507PubMedCrossRef
2.
go back to reference Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simoes M (1993) Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. Cancer 72:323–329PubMedCrossRef Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simoes M (1993) Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. Cancer 72:323–329PubMedCrossRef
3.
go back to reference Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharaoh P, Caldas C, Sorbrinho-Simoes M (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681–687PubMedCrossRef Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharaoh P, Caldas C, Sorbrinho-Simoes M (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681–687PubMedCrossRef
4.
go back to reference Daibo M, Itabashi M, Hirota T (1987) Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol 82:1016–1025PubMed Daibo M, Itabashi M, Hirota T (1987) Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol 82:1016–1025PubMed
5.
go back to reference Dijkhuizen SMM, Entius MM, Clement MJ, Polak MM, van den Berg FM, Craanen ME, Slebos RJC, Offerhaus GJA (1997) Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential. Gastroenterology 112:561–566PubMedCrossRef Dijkhuizen SMM, Entius MM, Clement MJ, Polak MM, van den Berg FM, Craanen ME, Slebos RJC, Offerhaus GJA (1997) Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential. Gastroenterology 112:561–566PubMedCrossRef
6.
go back to reference Dixon MF, Genta RM, Yardley JH, the Participants in the International Workshop on the Histopathology of Gastritis (1996) Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 20:1161–1181PubMedCrossRef Dixon MF, Genta RM, Yardley JH, the Participants in the International Workshop on the Histopathology of Gastritis (1996) Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 20:1161–1181PubMedCrossRef
7.
go back to reference El-Omar EM, Carrington M, Chow WH, McColl KE, Bream SW, Young HA, Herrera S, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402PubMedCrossRef El-Omar EM, Carrington M, Chow WH, McColl KE, Bream SW, Young HA, Herrera S, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402PubMedCrossRef
8.
go back to reference Elsborg L, Andersen D, Myrhe-Jensen O, Bastrup-Madsen P (1977) Gastric mucosal polyps in pernicious anaemia. Scand J Gastroenterol 12:49–52PubMed Elsborg L, Andersen D, Myrhe-Jensen O, Bastrup-Madsen P (1977) Gastric mucosal polyps in pernicious anaemia. Scand J Gastroenterol 12:49–52PubMed
9.
go back to reference Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF, Adami HO (1996) The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335:242–249PubMedCrossRef Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF, Adami HO (1996) The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335:242–249PubMedCrossRef
10.
go back to reference International Agency for Research on Cancer (IARC) (1994) Schistosomes, liver flukes and Helicobacter pylori. Working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 61:177–241 International Agency for Research on Cancer (IARC) (1994) Schistosomes, liver flukes and Helicobacter pylori. Working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 61:177–241
11.
go back to reference Knight T, Wyatt JI, Wilson A, Greaves S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J (1996) Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 73:819–824PubMed Knight T, Wyatt JI, Wilson A, Greaves S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J (1996) Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 73:819–824PubMed
12.
go back to reference Laxen F, Kekki M, Sipponen P, Siurala M (1983) The gastric mucosa in stomach with polyps: morphologic and dynamic evaluation. Scand J Gastroenterol 18:503–511PubMedCrossRef Laxen F, Kekki M, Sipponen P, Siurala M (1983) The gastric mucosa in stomach with polyps: morphologic and dynamic evaluation. Scand J Gastroenterol 18:503–511PubMedCrossRef
13.
go back to reference Leodolter A, Ebert M, Kahl S, Vieth M, Malfertheiner P (2003) Age-dependent prevalence of H. pylori associated gastritis phenotypes with increased risk for gastric cancer. Gastroenterology 124(Suppl):A648CrossRef Leodolter A, Ebert M, Kahl S, Vieth M, Malfertheiner P (2003) Age-dependent prevalence of H. pylori associated gastritis phenotypes with increased risk for gastric cancer. Gastroenterology 124(Suppl):A648CrossRef
14.
go back to reference Ljubicic N, Banic N, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, Hrabar D, Doko D, Doko M, Zowvak M, Mihatov S (1999) The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Eur J Gastroenterol Hepatol 11:722–730 Ljubicic N, Banic N, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, Hrabar D, Doko D, Doko M, Zowvak M, Mihatov S (1999) The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Eur J Gastroenterol Hepatol 11:722–730
15.
go back to reference Meining A, Bayerdörffer E, Müller P, Miehlke S, Lehn N, Hölzel D, Hatz R, Stolte M (1998) Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 432:311–314PubMedCrossRef Meining A, Bayerdörffer E, Müller P, Miehlke S, Lehn N, Hölzel D, Hatz R, Stolte M (1998) Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 432:311–314PubMedCrossRef
16.
go back to reference Meining A, Bayerdörffer E, Stolte M (1999) Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 11:717–720PubMedCrossRef Meining A, Bayerdörffer E, Stolte M (1999) Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 11:717–720PubMedCrossRef
17.
go back to reference Miehlke S, Hackelsberger A, Meining A, Hatz, Lehn N, Malfertheiner P (1998) Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 78:263–266PubMedCrossRef Miehlke S, Hackelsberger A, Meining A, Hatz, Lehn N, Malfertheiner P (1998) Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 78:263–266PubMedCrossRef
18.
go back to reference Mocek FW, Ward WW, Wolfson SE, Rumage WT, Wieman TJ (1994) Elimination of recurrent hyperplastic polyps by eradication of Helicobacter pylori. Ann Intern Med 120:1007–1008PubMed Mocek FW, Ward WW, Wolfson SE, Rumage WT, Wieman TJ (1994) Elimination of recurrent hyperplastic polyps by eradication of Helicobacter pylori. Ann Intern Med 120:1007–1008PubMed
19.
go back to reference Müller H, Rappel S, Wündisch T, Bayerdörffer E, Stolte M (2001) Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication. Digestion 64:30–39PubMedCrossRef Müller H, Rappel S, Wündisch T, Bayerdörffer E, Stolte M (2001) Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication. Digestion 64:30–39PubMedCrossRef
20.
go back to reference Nakano H, Persson B, Slezak P (1990) Study of the gastric mucosal background in patients with gastric polyps. Gastrointest Endosc 36:39–42PubMedCrossRef Nakano H, Persson B, Slezak P (1990) Study of the gastric mucosal background in patients with gastric polyps. Gastrointest Endosc 36:39–42PubMedCrossRef
21.
go back to reference Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, Sakurazawa T, Ariake K, Ishiik, Kumagai J, Zanizawa T (1998) Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Ann Intern Med 129:712–715PubMed Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, Sakurazawa T, Ariake K, Ishiik, Kumagai J, Zanizawa T (1998) Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Ann Intern Med 129:712–715PubMed
22.
go back to reference Orlowska J, Jarosz D, Pachlewski J, Butruk E (1995) Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 90:2152–2159PubMed Orlowska J, Jarosz D, Pachlewski J, Butruk E (1995) Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 90:2152–2159PubMed
23.
go back to reference Seifert E, Gail K, Weismüller J (1983) Gastric polypectomy—long term results (survey of 23 centers of Germany). Endoscopy 15:8–11PubMed Seifert E, Gail K, Weismüller J (1983) Gastric polypectomy—long term results (survey of 23 centers of Germany). Endoscopy 15:8–11PubMed
24.
go back to reference Sipponen P, Stolte M (1997) Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 29:671–678PubMed Sipponen P, Stolte M (1997) Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 29:671–678PubMed
25.
go back to reference Stolte M, Baumann H, Bethke B, Ritter M, Lauer E, Eidt H (1992) Active autoimmune gastritis without total atrophy of the glands. Z Gastroenterol 30:729–735PubMed Stolte M, Baumann H, Bethke B, Ritter M, Lauer E, Eidt H (1992) Active autoimmune gastritis without total atrophy of the glands. Z Gastroenterol 30:729–735PubMed
26.
go back to reference Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G (1994) Frequency, location and age and sex distribution of various types of gastric polyps. Endoscopy 22:203–207 Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G (1994) Frequency, location and age and sex distribution of various types of gastric polyps. Endoscopy 22:203–207
27.
go back to reference Stolte M (2001) Hyperplastic polyps of the stomach. Letter to the editor. Am J Surg Pathol 25:1342–1343PubMedCrossRef Stolte M (2001) Hyperplastic polyps of the stomach. Letter to the editor. Am J Surg Pathol 25:1342–1343PubMedCrossRef
28.
go back to reference Torbenson M, Abraham SC, Boitnott J, Yardley JH, Wu TT (2002) Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol 15:102–109PubMedCrossRef Torbenson M, Abraham SC, Boitnott J, Yardley JH, Wu TT (2002) Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol 15:102–109PubMedCrossRef
29.
go back to reference Uemura M, Okamoto S, Yamamoto S, Matsumara N, Ymaguche I, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789PubMedCrossRef Uemura M, Okamoto S, Yamamoto S, Matsumara N, Ymaguche I, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789PubMedCrossRef
30.
go back to reference Ye W, Nyrén O (2003) Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut 52:938–941PubMedCrossRef Ye W, Nyrén O (2003) Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut 52:938–941PubMedCrossRef
31.
go back to reference Zea-Iriarte WL, Sekine I, Istuno M, Makiyama K, Naito S, Nakayama T, Nishisawa-Takano JE, Hattori T (1996) Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci 41:377–386PubMedCrossRef Zea-Iriarte WL, Sekine I, Istuno M, Makiyama K, Naito S, Nakayama T, Nishisawa-Takano JE, Hattori T (1996) Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci 41:377–386PubMedCrossRef
Metadata
Title
Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?
Authors
Klaus Dirschmid
Claudia Platz-Baudin
Manfred Stolte
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 1/2006
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-005-0068-2

Other articles of this Issue 1/2006

Virchows Archiv 1/2006 Go to the issue